Carbapenemases in Enterobacteriaceae: Types and molecular epidemiology

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 32, Issue S4, 2014, Pages 4-9

  Martínez Martínez, Luis ^a,b   González López, Juan José ^c  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Beta lactams; Carbapenemases; Enterobacteriaceae; Multiresistance

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BACTERIAL ENZYME; BETA LACTAMASE; CARBAPENEMASE; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; INOSINE PHOSPHATE; MONOBACTAM DERIVATIVE; NEW DELHI METALLO BETA LACTAMASE; NON METALLO CARBAPENEMASE A; OXA 48 LIKE CARBAPENEMASE; QUINOLONE DERIVATIVE; SERRATIA MARCESCENS ENZYME; SULFONAMIDE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; VERONA INTEGRON ENCODED METALLO BETA LACTAMASE; BACTERIAL PROTEIN; CARBAPENEM DERIVATIVE; ZINC;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL STRAIN; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; ENTEROBACTERIACEAE; ENZYME ACTIVITY; HUMAN; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PHENOTYPE; PLASMID; REVIEW; ANTAGONISTS AND INHIBITORS; CLASSIFICATION; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; HEALTH; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CLAVULANIC ACID; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENES, BACTERIAL; GLOBAL HEALTH; HUMANS; PLASMIDS; SUBSTRATE SPECIFICITY; ZINC;

EID: 84920712225     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(14)70168-5     Document Type: Article

References (44)

1. Martínez-Martínez L, Pascual A, Hernández-Allés S, Álvarez-Díaz D, Suárez AI, Tran J, et al. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother. 1999;43:1669-73.
2. Yamachika S, Sugihara C, Kamai Y, Yamashita M. Correlation between penicillin-binding protein 2 mutations and carbapenem resistance in Escherichia coli. J Med Microbiol. 2013;62:429-36.
3. Ambler RP. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980;289:321-31.
4. Yigit H, Queenan AM, Anderson GJ, Domenech-Sánchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45:1151-61.
5. Walther-Rasmussen J, Hoiby N. Class A carbapenemases. J Antimicrob Chemother. 2007;60:470-82.
6. SME on a novel genomic island, SmarGI1-1. J Antimicrob Chemother. 2014;69:1825-9.
7. Rasmussen BA, Bush K, Keeney D, Yang Y, Hare R, O'Gara C, et al. Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob Agents Chemother. 1996;40:2080-6.
8. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18:263-72.
9. IMI-2 gene in a clinical Escherichia coli strain. Antimicrob Agents Chemother. 2012;56:1146-7.
10. Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers in Enterobacteriaceae worldwide. Clin Microbiol Infect. 2014;20:821-30.
11. Nordmann P, Mariotte S, Naas T, Labia R, Nicolas MH. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob Agents Chemother. 1993;37:939-46.
12. Bebrone C, Bogaerts P, Delbruck H, Bennink S, Kupper MB, Rezende de Castro R, et al. GES-18, a new carbapenem-hydrolyzing GES-type-lactamase from Pseudomonas aeruginosa that contains Ile80 and Ser170 residues. Antimicrob Agents Chemother. 2013;57:396-401.
13. Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2007;2:501-12.
14. Cuzon G, Naas T, Nordmann P. Functional characterization of Tn4401, a Tn3-based transposon involved in blaKPC gene mobilization. Antimicrob Agents Chemother. 2011;55:5370-3.
15. Carattoli A. Plasmids and the spread of resistance. Int J Med Microbiol. 2013;303:298-304.
16. Chen L, Chavda KD, Melano RG, Jacobs MR, Koll B, Hong T, et al. Comparative genomic analysis of KPC-encoding pKpQIL-like plasmids and their distribution in New Jersey and New York hospitals. Antimicrob Agents Chemother. 2014;58:2871-7.
17. Muñoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785-96.
18. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20:440-58.
19. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-β-Lactamase Gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046-54.
20. Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, et al. Cloning and characterization of bla VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother. 1999;43:1584-90.
21. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-Lactamases: the quiet before the storm? Clin Microbiol Rev. 2005;18:306-25.
22. Zhao W-H, Hu Z-Q. Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli. Future Microbiol. 2011;6:317-33.
23. Glasner C, Albiger B, Buist G, Tambic Andrasevic A, Cantón R, Carmeli Y, et al. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill. 2013;18:28.
24. Jain A, Hopkins KL, Turton J, Doumith M, Hill R, Loy R, et al. NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases. J Antimicrob Chemother. 2014;69:1777-84.
25. Johnson AP, Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol. 2013;62:499-513.
26. Qin S, Fu Y, Zhang Q, Qi H, Wen JG, Xu H, et al. High incidence and endemic spread of NDM-1 positive Enterobacteriaceae in Henan province, China. Antimicrob Agents Chemother. 2014;58:4275-82.
27. Zowawi HM, Sartor AL, Balkhy HH, Walsh TR, Al Johani SM, AlJindan RY, et al. Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the Countries of the Gulf Cooperation Council: Dominance of OXA-48 and NDM producers. Antimicrob Agents Chemother. 2014;58:3085-90.
28. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1991;35:147-51.
29. IMP among clinically isolated strains of Serratia marcescens. Antimicrob Agents Chemother. 1995;39:824-9.
30. Zhao W-H, Hu Z-Q. IMP-type metallo-β-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons. Crit Rev Microbiol. 2011;37:214-26.
31. Antunes NT, Lamoureaux TL, Toth M, Stewart NK, Frase H, Vakulenko SB. Class D β-lactamases: are they all carbapenemases? Antimicrob Agents Chemother. 2014;58:2119-25.
32. Hartl R, Widhalm S, Kerschner H, Apfalter P. Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae. Clin Microbiol Infects. 2013;19:E230-2.
33. Poirel L, Heritier C, Tolun V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48:15-22.
34. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012;67:1597-606.
35. Aubert D, Naas T, Heritier C, Poirel L, Nordmann P. Functional Characterization of IS1999, an IS4 family element involved in mobilization and expression of beta-lactam resistance genes. J Bacteriol. 2006;188:6506-14.
36. Carrer A, Poirel L, Yilmaz M, Akan OA, Feriha C, Cuzon G, et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother. 2010;54:1369-73.
37. Poirel L, Bonnin RA, Nordmann P. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother. 2012;56:559-62.
38. Potron A, Poirel L, Nordmann P. Derepressed transfer properties leading to the efficient spread of the plasmid encoding carbapenemase OXA-48. Antimicrob Agents Chemother. 2014;58:467-71.
39. Oteo J, Hernández JM, Espasa M, Fleites A, Sáez D, Bautista V, et al. Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain. J Antimicrob Chemother. 2013;68:317-21.
40. Poirel L, Castanheira M, Carrer A, Rodríguez CP, Jones RN, Smayevsky J, et al. OXA-163, an OXA-48-related class D beta-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother. 2011;55:2546-51.
41. Poirel L, Heritier C, Nordmann P. Chromosome-encoded ambler class D-lactamase of Shewanella oneidensis as a progenitor of carbapenem-hydrolyzing oxacillinase. Antimicrob Agents Chemother. 2004;48:348-51.
42. OXA-48-like variant, in Shewanella xiamenensis. PloS One. 2012;7:e48280.
43. Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe: Carbapenemase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18:413-31.
44. Evans BA, Amyes SGB. OXA β-lactamases. Clin Microbiol Rev. 2014;27:241-63.